SPY343.38+1.37 0.40%
DIA282.95+0.92 0.33%
IXIC11,516.49+37.51 0.33%

Morgan Stanley Maintains Underweight on Macrogenics, Raises Price Target to $13

Morgan Stanley maintains Macrogenics (NASDAQ:MGNX) with a Underweight and raises the price target from $12 to $13.

· 10/13/2020 10:10
Morgan Stanley maintains Macrogenics (NASDAQ:MGNX) with a Underweight and raises the price target from $12 to $13.